BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6333389)

  • 1. Restricted recognition of H-2 subregion coded alloantigens in delayed-type hypersensitivity.
    Bianchi AT; Bril H; Hussaarts-Odijk LM; Benner R
    Immunogenetics; 1984; 20(4):347-57. PubMed ID: 6333389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions.
    Benner R; Wolters EA; Bril H; Molendijk A; van Oudenaren A
    Immunol Rev; 1985 Dec; 88():25-57. PubMed ID: 2935486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary delayed type hypersensitivity to H-2 subregion-coded alloantigens.
    Bianchi AT; Hussaarts-Odijk LM; Benner R
    Immunobiology; 1985 Sep; 170(3):192-202. PubMed ID: 3863787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of delayed-type hypersensitivity to third party "bystander" alloantigens by antigen-specific suppressor T cells.
    Bianchi AT; Hussaarts-Odijk LM; Benner R
    Cell Immunol; 1983 Oct; 81(2):333-44. PubMed ID: 6227391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens.
    Bianchi AT; Hussaarts-Odijk LM; Wolters EA; Molendijk A; Benner R
    J Immunol; 1986 Jul; 137(2):433-42. PubMed ID: 2941481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2 restriction of virus-specific T-cell-mediated effector functions in vivo. II. Adoptive transfer of delayed-type hypersensitivity to murine lymphocytic choriomeningits virus is restriced by the K and D region of H-2.
    Zinkernagel RM
    J Exp Med; 1976 Sep; 144(3):776-87. PubMed ID: 1085340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen-specific suppressor t cells can also suppress the in vivo immune response to unrelated alloantigens.
    Bianchi AT; Bril H; Benner R
    Nature; 1983 Feb 17-23; 301(5901):614-6. PubMed ID: 6219292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential influence of 2'-deoxyguanosine on the induction and expression of suppressor T lymphocytes in vivo.
    Bril H; van den Akker TW; Hussaarts-Odijk LM; Benner R
    Cell Immunol; 1985 Feb; 90(2):531-8. PubMed ID: 3155658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell lines active in the delayed-type hypersensitivity reaction (DTH).
    Weiss S; Dennert G
    J Immunol; 1981 May; 126(5):2031-5. PubMed ID: 6971319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of delayed-type hypersensitivity. VII. The role of I-J subregion gene products in the inhibition of delayed-type hypersensitivity to major histocompatibility antigens by specific suppressor T cells.
    Liew FY
    Eur J Immunol; 1981 Nov; 11(11):883-8. PubMed ID: 6173227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection.
    Leung KN; Ada GL; McKenzie IF
    J Exp Med; 1980 Apr; 151(4):815-26. PubMed ID: 6966309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism of T lymphocyte subsets in the response to Mls-locus coded antigens during graft-versus-host reaction.
    Bril H; Molendijk-Lok BD; Hussaarts-Odijk LM; Benner R
    Cell Immunol; 1984 Feb; 83(2):370-8. PubMed ID: 6607131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of suppressor T cells after local immunization with histocompatibility antigens.
    Molendijk A; Bril H; Hussaarts-Odijk LM; van Gurp RJ; Benner R
    Cell Immunol; 1988 May; 113(2):480-93. PubMed ID: 2965991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responsiveness to H-2-subregion-coded antigens in graft versus host and host versus graft reactions.
    Wolters EA; van der Kwast TH; Odijk LM; Benner R
    Cell Immunol; 1981 Jan; 57(2):389-99. PubMed ID: 6971165
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction and suppression of delayed-type hypersensitivity to non-MHC antigens during lethal graft-versus-host reaction.
    Pritchard LL; Huchet R; Bruley-Rosset M; Riché N; Mishal Z; Halle-Pannenko O
    J Immunol; 1992 Jul; 149(1):45-52. PubMed ID: 1351502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an inducer-suppressor T cell in the regulation of DTH to alloantigens.
    Molendijk A; van Gurp RJ; Benner R
    Transplant Proc; 1987 Oct; 19(5):4261-4. PubMed ID: 2960054
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of epidermal cells in the induction of delayed-type hypersensitivity to alloantigens.
    Tamaki K; Furue M
    J Invest Dermatol; 1985 Jul; 85(1):20-4. PubMed ID: 3891874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.